Tower Research Capital LLC (Trc) Ultragenyx Pharmaceutical Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 16,827 shares of RARE stock, worth $662,310. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,827
Previous 853
1872.68%
Holding current value
$662,310
Previous $47,000
1404.26%
% of portfolio
0.01%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding RARE
# of Institutions
344Shares Held
84.3MCall Options Held
675KPut Options Held
846K-
Vanguard Group Inc Valley Forge, PA10MShares$395 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$221 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.3MShares$169 Million0.57% of portfolio
-
State Street Corp Boston, MA2.72MShares$107 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$98.9 Million0.01% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.76B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...